METiS Therapeutics

METiS Therapeutics, a biopharmaceutical company based in Cambridge, Massachusetts, has secured USD 100 million in a Series C financing round. The round was led by CICC Capital, with additional investment from China Taiping Insurance. This latest funding round brings the total capital raised by the Sino-US firm to USD 300…